ArticleInvestigational new drugs2025
Vebreltinib: a promising milestone in targeted therapy for METex14-mutant NSCLC.
LinRui Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleInvestigational new drugs2025
LinRui Ma et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.